EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS162-05650 
Organism
Homo sapiens 
Tissue/cell
Plasma_cell_myeloma 
Coordinate
chr2:109210440-109211940 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ESR1MA0112.3chr2:109211568-109211585AAGGTCATACCGACCTT-6.36
SRFMA0083.3chr2:109211823-109211839CTACCTTATATGGGAA-6.44
Stat6MA0520.1chr2:109210699-109210714AATTCTGTGGAAGTG-6.05
Number of super-enhancer constituents: 13             
IDCoordinateTissue/cell
SE_00150chr2:109209249-109212599Adipose_Nuclei
SE_02443chr2:109208425-109212791Astrocytes
SE_09428chr2:109200100-109212863CD14
SE_13458chr2:109209277-109212695CD34_Primary_RO01536
SE_14591chr2:109209543-109212707CD4_Memory_Primary_7pool
SE_37112chr2:109200131-109213130HSMMtube
SE_38351chr2:109208413-109213057HUVEC
SE_46267chr2:109208606-109212857Osteoblasts
SE_51957chr2:109208439-109212626Skeletal_Muscle_Myoblast
SE_56245chr2:109208465-109212648u87
SE_58426chr2:109210411-109254632Ly1
SE_62462chr2:109181827-109254696Tonsil
SE_63750chr2:109208425-109212640HSMM
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr2109210699109211038
chr2109211421109211903
Enhancer Sequence
TGAAATAGCT AGAATAGTAA CAAAGCTCCC TTTAAATTCA GACAATAGCA GTGAGCTACT 60
GGTAACAGCC CAAAGGAGAA AATGAGCAGC AGCCAGAATT TTGAGATTAA TTTTAATAAT 120
TTATTAATGA ATGCACCAGC AGAGAAGAGG TGGGAAGGAT ATGGTCGACA AGTGGTAGGA 180
GTAAAAAATT CAGCTGTGGG GAAGGGGTAG CTTTTGCTTA GAAAGTTCAC CACAGACCCC 240
TGCCCTCTAA GTTATGGTGA ATTCTGTGGA AGTGATTAGA GTGGAGAAAA AGGAACAAAG 300
AGGGTTGGAA TCCAGACGTT CCATGACTAA CCCCAAGATG ACTAAACCAG CTACTGAATG 360
CACCCACAGA AAGGGAAGTG ACATTTACTG AGAACACATT TAGTGTTGCT GAACGCTTAA 420
AATGCTTTCT TTGTGTTCTC AGTCCTTACC AGTCTGTGAG GGGGGTTTAT TTTGTCTACA 480
TTACAGATGA AGAATCTCAC CTGCAAATGA AGAAAGTTGG CTGGCCGACA GGAGATCGTT 540
TGAAATGAAA GGATTCCAGG GTTTCTTTCT ACTGAGCGTA TTCAATAAGC AGGGCTTATT 600
ATACTATCTA GAATGGTGCT ATCCTGTAGA AATACAATGT AAGCAGCATG TGTAGTTTTA 660
AGATTTTCTA GTAGCCATTT AAAACAGGAA AAAAGAGATA GGGAAGATTA ATTTTAATAA 720
TATGTTTAAT TTAACCCAGT ATATCAAACT GTCATCATGT CCAAGCTATA TACATATCAT 780
GTCATCAGCA TTTTAAAGTT ACCAGGAGAA TTCAGTGGGT ACTTTAAAGT CCATCTGAAT 840
TCAGACTAGC CACATTTCAA GTTGCTACAT GTGACTACTG GCTACCAAAG TAGACAGCAT 900
AGCTCTAAAA AAAAGGTAGA CAGACTCATC CTAAAAAAAA ATCGAATGTA GAGGCCCTGC 960
TTTGAAGTCA TTGAGAGGAA TTATGGTGGG GCAAGAAAGC AGCTTCACCT GAGATGGAAA 1020
GCTCTGTGGA AGGAAGGTAC CATACATAAA AGCAGGGCTG CTCTTGAAAG AATGTGACCA 1080
TATCATGCAA GGACATTACT GACTGAAGGG CTATTTATGG AGAGCAGTAA GGTCATACCG 1140
ACCTTTATCA CCACTGCCAG TCGTGACCAC AGGAAGGCCC TGTGGTGTTG ACTGCTAGAT 1200
GCTGAACCGT ATTTGGGTGG GGGTTGCGAG GATGCTGTGT CTTGGCAAAT CTACTAACCA 1260
TTAGGAGTGG AAACCACAGC CTTTAATGTA TGTGTGGATG TCATTCCCAA AGAATCTTTT 1320
CTTCCAGTGC CTTTTTCAGA TGAGGAGGTG TAATGTGTGC TTGAGGAAGT AAGCATGAAC 1380
AAACTACCTT ATATGGGAAT TCCCAGACCT CAGCTCCACC CAGACCAAGA TAAATGATGG 1440
TTTCAGACTG CTATTCCAGC AAAACAGGGA CCATCCTATA TTTATAATAT TCAGTCATTT 1500